NCT02071914View on ClinicalTrials.gov

A Study to Evaluate the Efficacy and Safety of CT-P27 in an Influenza Challenge Model

PHASE2CompletedINTERVENTIONAL

Enrollment

81

Participants

Timeline

Start Date

February 15, 2014

Primary Completion Date

May 19, 2014

Study Completion Date

June 19, 2014

Conditions

Influenza A

Interventions

DRUG

CT-P27

Influenza A treatment drug.

DRUG

Placebo

Placebo.

Trial Locations (1)

Unknown

Retroscreen Virology Ltd., London

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Celltrion

INDUSTRY